陈 丹,王凯冰,李加桩.血清VEGFR-2浓度变化预测肝癌患者TACE近期疗效的研究[J].中国肿瘤,2017,26(6):476-481.
血清VEGFR-2浓度变化预测肝癌患者TACE近期疗效的研究
Prediction of Serum VEGFR-2 Concentration on the Short-term Effects of TACE in Patients with Hepatocellular Carcinoma
投稿时间:2016-10-20  
DOI:10.11735/j.issn.1004-0242.2017.06.A012
中文关键词:  肝肿瘤  TACE  VEGFR-2  酶联免疫吸附法
英文关键词:hepatocellular neoplasms  TACE  VEGFR-2  ELISA
基金项目:吴阶平医学基金会临床科研专项资助基金(320.6750.15179)
作者单位
陈 丹 哈尔滨医科大学附属肿瘤医院 
王凯冰 哈尔滨医科大学附属第二医院 
李加桩 哈尔滨医科大学附属肿瘤医院 
摘要点击次数: 1886
全文下载次数: 466
中文摘要:
      摘 要:[目的] 研究血清VEGFR-2浓度变化与肝癌患者经肝动脉化疗栓塞术(TACE)治疗后近期疗效的相关性。[方法] 采用ELISA方法检测24例晚期肝癌患者TACE治疗前后血清VEGFR-2的表达水平,并分析VEGFR-2浓度变化与晚期肝癌患者临床病理的关系。[结果] 血清VEGFR-2浓度与肿瘤数目、肝硬化病史有关(P<0.05);PFS与肿瘤数目、门脉癌栓、肿瘤大小、肝硬化有关(P<0.05)。治疗1个月后疾病缓解5例,疾病稳定14例,疾病进展5例,mPFS分别为7.84、4.78、3.68个月(P<0.05)。[结论] TACE术后1个月血清VEGFR-2浓度变化与PFS有关,血清VEGFR-2浓度变化可能成为肝癌TACE治疗潜在的近期疗效预测指标。
英文摘要:
      Abstract:[Purpose] To study the correlation between the changes of serum VEGFR-2 concentration and short-term effects of hepatocellular carcinoma after transcatheter arterial chemoembolization. [Methods] Serum VEGF-2 expression level,measured by quatitative sandwich enzyme-linked immunosorbentassay(ELISA),was measured before TACE 1 day and 1 month after TACE in 24 patients with HCC and the correlation between the change of VEGFR-2 concentration and clinical pathological characteristics of patients with advanced hepatocellular carcinoma was analyzed. [Results] The serum VEGFR-2 concentration was significantly correlated with the tumor size and hepatic cirrhosis(P<0.05). The progress free survival(PFS) was significantly correlated with the tumor size,portal vein invasion,tumer number and hepatic cirrhosis(P<0.05). There were 5 patients with partial response after one month of treatment,14 patients with stable disease,5 patients with progressive disease. The PFS was 7.84,4.71 and 3.68 months,respectively(P<0.05). [Conclusion] The change of serum VEGFR-2 concentration in early stage is related to PFS and VEGFR-2 may be a potential indicator for predicting the short-term effects of TACE in hepatocellular carcinoma.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器